GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige Biologics Co Ltd (XKRX:334970) » Definitions » Sale Of Investment

Prestige Biologics Co (XKRX:334970) Sale Of Investment : ₩0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Prestige Biologics Co Sale Of Investment?

Prestige Biologics Co's sale of investment for the three months ended in Sep. 2024 was ₩0 Mil. It means Prestige Biologics Co gained ₩0 Mil from selling investments. Prestige Biologics Co's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was ₩0 Mil.

Compared with last quarter (₩0 Mil in Jun. 2024 ), Prestige Biologics Co gained the same money from selling investments in Sep. 2024 (₩0 Mil).


Prestige Biologics Co Sale Of Investment Historical Data

The historical data trend for Prestige Biologics Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Biologics Co Sale Of Investment Chart

Prestige Biologics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Jun23 Jun24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only 15,104.40 - - - -

Prestige Biologics Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Prestige Biologics Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prestige Biologics Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Prestige Biologics Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Prestige Biologics Co Business Description

Traded in Other Exchanges
N/A
Address
197, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161
Prestige Biologics Co Ltd is a CDMO-dedicated company that provides solutions of development and manufacturing tasks throughout the stages from the research/development, engineering, clinical production, commercial production, clinical support, and IND & BLA filing of biopharmaceutical products. Its product candidate includes HD201 (Herceptin Biosimilar).

Prestige Biologics Co Headlines

No Headlines